NCT00049244View on ClinicalTrials.gov

BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer

PHASE1UnknownINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Conditions
Breast Cancer
Interventions
DRUG

capecitabine

DRUG

ixabepilone

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Lead Sponsor

R-Pharm
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

R-Pharm

INDUSTRY